Asa Hatami, Ph.D.

JAD profile

Affiliation(s): 

Sangamo Therapeutics

Areas of Interest: 

neurodegeneration, amyloid, protein misfolding, Alzheimer's diease, Parkinson's disease, Huntington's disease, Monoclonal antibodies, traumatic brain injury, drug discovery